Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics

Proteomics

Volumn 15, Issue 2-3, 2015, Pages 520-531

  Osinalde, Nerea ^a   Sanchez Quiles, Virginia ^a   Akimov, Vyacheslav ^a   Guerra, Barbara ^a   Blagoev, Blagoy ^a   Kratchmarova, Irina ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cell biology; IL 15; IL 2; Quantitative phosphoproteomics; Signaling; SILAC

Indexed keywords

CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PROTEIN KINASE B; RAS PROTEIN; STAT PROTEIN; TYROSINE; INTERLEUKIN 7;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; ISOTOPE LABELING; LYMPHOMA CELL LINE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STABLE ISOTOPE LABELING BY AMINO ACIDS IN CELL CULTURE; T-CELL LYMPHOMA CELL LINE; CYTOLOGY; IMMUNOLOGY; PHOSPHORYLATION; T LYMPHOCYTE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; ENDOCYTOSIS; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-7; PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84921367335     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400194     Document Type: Article

References (57)

1. Rochman, Y., Spolski, R., Leonard, W. J., New insights into the regulation of T cells by gamma family cytokines. Nat. Rev. Immunol. 2009, 9, 480-490.
2. + cutaneous T-cell lymphoma cells. Cancer Res. 2008, 68, 1083-1091.
3. Ring, A. M., Lin, J. X., Feng, D., Mitra, S. et al., Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. 2012, 13, 1187-1195.
4. + T cell homeostasis. J. Exp. Med. 2004, 200, 825-834.
5. Liao, W., Lin, J. X., Wang, L., Li, P., Leonard, W. J., Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 2011, 12, 551-559.
6. Lenardo, M. J., Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991, 353, 858-861.
7. Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H. et al., IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. USA 2000, 97, 11445-11450.
8. Ma, A., Boone, D. L., Lodolce, J. P., The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J. Exp. Med. 2000, 191, 753-756.
9. Stonier, S. W., Schluns, K. S., Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 2010, 127, 85-92.
10. Tesch, H., Gunther, A., Abts, H., Jucker, M. et al., Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. Am. J. Pathol. 1993, 142, 1714-1720.
11. Wu, S., Fischer, L., Gokbuget, N., Schwartz, S. et al., Expression of interleukin 15 in primary adult acute lymphoblastic leukemia. Cancer 2010, 116, 387-392.
12. Fehniger, T. A., Cooper, M. A., Caligiuri, M. A., Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev. 2002, 13, 169-183.
13. Jakobisiak, M., Golab, J., Lasek, W., Interleukin 15 as a promising candidate for tumor immunotherapy. Cytokine Growth Factor Rev. 2011, 22, 99-108.
14. Gadina, M., Hilton, D., Johnston, J. A., Morinobu, A. et al., Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 2001, 13, 363-373.
15. Macek, B., Mann, M., Olsen, J. V., Global and site-specific quantitative phosphoproteomics: principles and applications. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 199-221.
16. Rigbolt, K. T., Blagoev, B., Quantitative phosphoproteomics to characterize signaling networks. Semin. Cell Dev. Biol. 2012, 23, 863-871.
17. Schreiber, T. B., Mausbacher, N., Breitkopf, S. B., Grundner-Culemann, K., Daub, H., Quantitative phosphoproteomics-an emerging key technology in signal-transduction research. Proteomics 2008, 8, 4416-4432.
18. Blagoev, B., Kratchmarova, I., Ong, S. E., Nielsen, M. et al., A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 2003, 21, 315-318.
19. Dengjel, J., Kratchmarova, I., Blagoev, B., Receptor tyrosine kinase signaling: a view from quantitative proteomics. Mol. Biosyst. 2009, 5, 1112-1121.
20. Francavilla, C., Rigbolt, K. T., Emdal, K. B., Carraro, G. et al., Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs. Mol. Cell 2013, 51, 707-722.
21. Kratchmarova, I., Blagoev, B., Haack-Sorensen, M., Kassem, M., Mann, M., Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308, 1472-1477.
22. Osinalde, N., Moss, H., Arrizabalaga, O., Omaetxebarria, M. J. et al., Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. J. Proteomics 2011, 75, 177-191.
23. Arneja, A., Johnson, H., Gabrovsek, L., Lauffenburger, D. A., White, F. M., Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration. J. Immunol. 2014, 192, 123-135.
24. Zambricki, E., Shigeoka, A., Kishimoto, H., Sprent, J. et al., Signaling T-cell survival and death by IL-2 and IL-15. Am. J. Transplant. 2005, 5, 2623-2631.
25. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., Mann, M., In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 2006, 1, 2856-2860.
26. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., Jorgensen, T. J., Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 2005, 4, 873-886.
27. Rigbolt, K. T., Prokhorova, T. A., Akimov, V., Henningsen, J. et al., System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. 2011, 4, rs3.
28. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B. et al., Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127, 635-648.
29. Hori, T., Uchiyama, T., Tsudo, M., Umadome, H. et al., Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 1987, 70, 1069-1072.
30. Yamada, Y., Sugawara, K., Hata, T., Tsuruta, K. et al., Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells. Blood 1998, 91, 4265-4272.
31. Johnston, J. A., Bacon, C. M., Finbloom, D. S., Rees, R. C. et al., Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 1995, 92, 8705-8709.
32. Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B. et al., PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012, 40, D261-D270.
33. Zhang, Q., Lee, B., Korecka, M., Li, G. et al., Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia. Leuk. Res. 1999, 23, 373-384.
34. Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S. et al., Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 1994, 370, 153-157.
35. Kirken, R. A., Rui, H., Malabarba, M. G., Howard, O. M. et al., Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Cytokine 1995, 7, 689-700.
36. Zhou, Y. J., Hanson, E. P., Chen, Y. Q., Magnuson, K. et al., Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc. Natl. Acad. Sci. USA 1997, 94, 13850-13855.
37. Beadling, C., Ng, J., Babbage, J. W., Cantrell, D. A., Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 1996, 15, 1902-1913.
38. Lin, J. X., Migone, T. S., Tsang, M., Friedmann, M. et al., The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995, 2, 331-339.
39. Gouilleux, F., Wakao, H., Mundt, M., Groner, B., Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 1994, 13, 4361-4369.
40. Delespine-Carmagnat, M., Bouvier, G., Bertoglio, J., Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain. Eur. J. Immunol. 2000, 30, 59-68.
41. Friedmann, M. C., Migone, T. S., Russell, S. M., Leonard, W. J., Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 1996, 93, 2077-2082.
42. Ravichandran, K. S., Igras, V., Shoelson, S. E., Fesik, S. W., Burakoff, S. J., Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc. Natl. Acad. Sci. USA 1996, 93, 5275-5280.
43. Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G. et al., Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992, 360, 689-692.
44. Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., Bowtell D., The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 1993, 363, 83-85.
45. Li, S., Couvillon, A. D., Brasher, B. B., Van Etten, R. A., Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. EMBO J. 2001, 20, 6793-6804.
46. Lundin Brockdorff, J., Woetmann, A., Mustelin, T., Kaltoft, K. et al., SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells. Cytokine 2002, 20, 141-147.
47. Gadina, M., Sudarshan, C., Visconti, R., Zhou, Y. J. et al., The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines. J. Biol. Chem. 2000, 275, 26959-26966.
48. Remillard, B., Petrillo, R., Maslinski, W., Tsudo, M. et al., Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 1991, 266, 14167-14170.
49. Burkhardt, J. K., Carrizosa, E., Shaffer, M. H., The actin cytoskeleton in T cell activation. Annu. Rev. Immunol. 2008, 26, 233-259.
50. Basquin, C., Malarde, V., Mellor, P., Anderson, D. H. et al., The signalling factor PI3K is a specific regulator of the clathrin-independent dynamin-dependent endocytosis of IL-2 receptors. J. Cell Sci. 2013, 126, 1099-1108.
51. Grassart, A., Dujeancourt, A., Lazarow, P. B., Dautry-Varsat, A., Sauvonnet, N., Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2. EMBO Rep. 2008, 9, 356-362.
52. Mousavi, S. A., Malerod, L., Berg, T., Kjeken, R., Clathrin-dependent endocytosis. Biochem. J. 2004, 377, 1-16.
53. Popovic, D., Dikic, I., TBC1D5 and the AP2 complex regulate ATG9 trafficking and initiation of autophagy. EMBO Rep. 2014, 4, 392-401.
54. Carbone, R., Fre, S., Iannolo, G., Belleudi, F. et al., eps15 and eps15R are essential components of the endocytic pathway. Cancer Res. 1997, 57, 5498-5504.
55. Salcini, A. E., Confalonieri, S., Doria, M., Santolini, E. et al., Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module. Genes Dev. 1997, 11, 2239-2249.
56. Raiborg, C., Bache, K. G., Mehlum, A., Stang, E., Stenmark, H., Hrs recruits clathrin to early endosomes. EMBO J. 2001, 20, 5008-5021.
57. Vizcaíno, J. A, Côté, R. G., Csordas, A., Dianes, J. A. et al., The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 2012, doi: 10.1093/nar/gks1262.